140 related articles for article (PubMed ID: 9391546)
21. Are myelodysplastic syndromes and acute myeloid leukaemia occurring during the course of lymphoma always therapy related?
Bigenwald C; Harel S; Chevignon F; Roos-Weil D; Bernard OA; Amorim S; Brice P; Adès L; Nloga AM; Sébert M; Braun T; Eclache V; Thieblemont C; Fenaux P
Br J Haematol; 2018 Jan; 180(2):304-308. PubMed ID: 27662562
[No Abstract] [Full Text] [Related]
22. Secondary myelodysplastic syndromes and leukaemias.
Levine EG; Bloomfield CD
Clin Haematol; 1986 Nov; 15(4):1037-80. PubMed ID: 3552347
[TBL] [Abstract][Full Text] [Related]
23. A case of treatment-related myelodysplastic syndrome and acute myelogenous leukemia following high-dose chemotherapy with autologous stem cell transplantation for non-Hodgkin's lymphoma.
Jang GD; Kim SW; Suh CW; Kim EK; Bahng HS; Jeong YH; Park IG; Kim WK; Kim SH; Suh EJ; Park CJ; Ji HS; Lee JS
J Korean Med Sci; 2002 Aug; 17(4):555-9. PubMed ID: 12172056
[TBL] [Abstract][Full Text] [Related]
24. Treatment of therapy-related leukemia and myelodysplastic syndrome.
Kantarjian HM; Estey EH; Keating MJ
Hematol Oncol Clin North Am; 1993 Feb; 7(1):81-107. PubMed ID: 7680643
[TBL] [Abstract][Full Text] [Related]
25. Myelodysplasia and acute leukemia following high-dose chemotherapy and autologous bone marrow or peripheral blood stem cell transplantation.
Sobecks RM; Le Beau MM; Anastasi J; Williams SF
Bone Marrow Transplant; 1999 Jun; 23(11):1161-5. PubMed ID: 10382956
[TBL] [Abstract][Full Text] [Related]
26. Microsatellite instability and p53 mutations in therapy-related leukemia suggest mutator phenotype.
Ben-Yehuda D; Krichevsky S; Caspi O; Rund D; Polliack A; Abeliovich D; Zelig O; Yahalom V; Paltiel O; Or R; Peretz T; Ben-Neriah S; Yehuda O; Rachmilewitz EA
Blood; 1996 Dec; 88(11):4296-303. PubMed ID: 8943866
[TBL] [Abstract][Full Text] [Related]
27. Myelodysplastic syndrome in a child with a history of medulloblastoma.
Akyüz C; Emir S; Güler N; Tüker A; Büyükpamukçu M
Turk J Pediatr; 1998; 40(1):131-4. PubMed ID: 9673540
[TBL] [Abstract][Full Text] [Related]
28. Secondary myeloid leukemia and myelodysplastic syndromes in patients treated for Hodgkin's disease: a report from the German Hodgkin's Lymphoma Study Group.
Josting A; Wiedenmann S; Franklin J; May M; Sieber M; Wolf J; Engert A; Diehl V;
J Clin Oncol; 2003 Sep; 21(18):3440-6. PubMed ID: 12668650
[TBL] [Abstract][Full Text] [Related]
29. Characteristics and outcomes of patients with multiple myeloma who develop therapy-related myelodysplastic syndrome, chronic myelomonocytic leukemia, or acute myeloid leukemia.
Pemmaraju N; Shah D; Kantarjian H; Orlowski RZ; Nogueras González GM; Baladandayuthapani V; Jain N; Wagner V; Garcia-Manero G; Shah J; Ravandi F; Pierce S; Takahashi K; Daver N; Nazha A; Verstovsek S; Jabbour E; De Lima M; Champlin R; Cortes J; Qazilbash MH
Clin Lymphoma Myeloma Leuk; 2015 Feb; 15(2):110-4. PubMed ID: 25107338
[TBL] [Abstract][Full Text] [Related]
30. Myelodysplastic Syndromes and Acute Myeloid Leukemia After Radiotherapy for Prostate Cancer: A Population-Based Study.
Wang R; Zeidan AM; Yu JB; Soulos PR; Davidoff AJ; Gore SD; Huntington SF; Gross CP; Ma X
Prostate; 2017 Apr; 77(5):437-445. PubMed ID: 27868212
[TBL] [Abstract][Full Text] [Related]
31. Characteristics and Predictors for Secondary Leukemia and Myelodysplastic Syndrome in Ewing and Osteosarcoma Survivors.
Sanford NN; Miao R; Wang H; Goldberg S; Jacobson A; Brunner AM; Cote GM; Yock TI; Ebb DH; Chen YB; Jee KW; Hornicek F; DeLaney TF; Choy E; Chen YL
Int J Radiat Oncol Biol Phys; 2019 Jan; 103(1):52-61. PubMed ID: 30165126
[TBL] [Abstract][Full Text] [Related]
32. Therapy-related myeloid leukemia.
Thirman MJ; Larson RA
Hematol Oncol Clin North Am; 1996 Apr; 10(2):293-320. PubMed ID: 8707757
[TBL] [Abstract][Full Text] [Related]
33. Defining AML and MDS second cancer risk dynamics after diagnoses of first cancers treated or not with radiation.
Radivoyevitch T; Sachs RK; Gale RP; Molenaar RJ; Brenner DJ; Hill BT; Kalaycio ME; Carraway HE; Mukherjee S; Sekeres MA; Maciejewski JP
Leukemia; 2016 Feb; 30(2):285-94. PubMed ID: 26460209
[TBL] [Abstract][Full Text] [Related]
34. Risk factors for second acute myeloid leukemia/myelodysplastic syndrome among survivors of non-Hodgkin lymphoma.
Lam CJ; Curtis RE; Dores GM; Engels EA; Caporaso NE; Polliack A; Warren JL; Young HA; Levine PH; Elmi AF; Fraumeni JF; Tucker MA; Morton LM
Leukemia; 2016 May; 30(5):1187-90. PubMed ID: 26369985
[No Abstract] [Full Text] [Related]
35. Secondary Acute Leukemia in Sarcoma Patients: A Population-Based Study.
Sanford NN; Martin AM; Brunner AM; Cote GM; Choy E; DeLaney TF; Aizer AA; Chen YL
Int J Radiat Oncol Biol Phys; 2018 Mar; 100(3):687-694. PubMed ID: 29413281
[TBL] [Abstract][Full Text] [Related]
36. The BCL2L10 Leu21Arg variant and risk of therapy-related myeloid neoplasms and de novo myelodysplastic syndromes.
Fabiani E; Fianchi L; Falconi G; Boncompagni R; Criscuolo M; Guidi F; La Brocca A; Hohaus S; Leone G; Voso MT
Leuk Lymphoma; 2014 Jul; 55(7):1538-43. PubMed ID: 24047476
[TBL] [Abstract][Full Text] [Related]
37. [Second neoplasms as a late complication of the treatment of Hodgkin's disease].
Morales MD; González FA; Villegas A; del Potro E; Díaz Mediavilla J; Martínez R; Alvarez A; Colomé JA
Sangre (Barc); 1992 Dec; 37(6):429-33. PubMed ID: 1293793
[TBL] [Abstract][Full Text] [Related]
38. Cytogenetics, not just previous therapy, determines the course of therapy-related myeloid neoplasms.
Larson RA
J Clin Oncol; 2012 Jul; 30(19):2300-2. PubMed ID: 22585693
[No Abstract] [Full Text] [Related]
39. Case-control study on the therapy of childhood cancer and the occurrence of second malignant neoplasms in Germany.
Kaatsch P; Reinisch I; Spix C; Berthold F; Janka-Schaub G; Mergenthaler A; Michaelis J; Blettner M
Cancer Causes Control; 2009 Aug; 20(6):965-80. PubMed ID: 19263232
[TBL] [Abstract][Full Text] [Related]
40. The risk of acute leukemia in patients treated for Hodgkin's disease is significantly higher aft [see bined modality programs than after chemotherapy alone and is correlated with the extent of radiotherapy and type and duration of chemotherapy: a case-control study.
Brusamolino E; Anselmo AP; Klersy C; Santoro M; Orlandi E; Pagnucco G; Lunghi F; Maurizi-Enrici R; Baroni CD; Lazzarino M; Mandelli F; Bernasconi C
Haematologica; 1998 Sep; 83(9):812-23. PubMed ID: 9825578
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]